II.1)
Scope of the procurement
Provision of manual blood grouping and red cell antibody screening and identification equipment, reagents and consumables (controls) for the period 01st April 2020 - 31st March 2025 +12m+12m
Reference number:
MED2092
33696100
-
Blood-grouping reagents
Supplies
II.1.4)
Short description
Supply of manual blood grouping and red cell antibody screening and identification equipment, reagents and consumables (controls).
Methodology used must be direct agglutination for blood grouping and indirect antiglobulin testing for red cell antibody screening.
Bidders are requested to provide responses in the form of:
1. capital purchase & consumable
2. reagent rental/lease proposals
Full delivery, installation and commissioning of equipment is required prior to 27.03.2020.
Following this initial procurement, the Trust may consider at a later stage adding this contract into an existing Managed Service contract, and it’s asking bidders to advise if this would present any issues with the proposals submitted.
The contract period is to be for a period of minimum 5 years with an anticipated start date of 01.04.2020, and with an option to extend for 2 further periods of 1 year each.
The estimated value of the annual reagent contract is £43,000
II.1.5)
Estimated total value
Value excluding VAT: 200000.00
GBP
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2.2)
Additional CPV code(s)
33696100
-
Blood-grouping reagents
II.2.3)
Place of performance
Main site or place of performance:
Stoke on Trent and Stafford
II.2.4)
Description of the procurement
Supply of manual blood grouping and red cell antibody screening and identification equipment, reagents and consumables (controls).
Methodology used must be direct agglutination for blood grouping and indirect antiglobulin testing for red cell antibody screening.
Bidders are requested to provide responses in the form of:
1. capital purchase & consumable
2. reagent rental/lease proposals
Full delivery, installation and commissioning of equipment is required prior to 27.03.2020.
Following this initial procurement, the Trust may consider at a later stage adding this contract into an existing Managed Service contract, and it’s asking bidders to advise if this would present any issues with the proposals submitted.
The contract period is to be for a period of minimum 5 years with an anticipated start date of 01.04.2020, and with an option to extend for 2 further periods of 1 year each.
The estimated value of the annual reagent contract is £43,000
Methodology used must be direct agglutination for blood grouping and indirect antiglobulin testing for red cell antibody screening.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 200000.00
GBP
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
yes
Description of renewals:
Potential to extend for up to 2 x 12 months periods beyond original 5 year contract dates
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no